topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and COVID-19.

 

The undersigned scientific and professional societies, higher education associations, universities, and research institutions are writing to express their opposition to a provision in the Commercializing on Small Business Innovation Act of 2016 (HR 4783) which would increase the SBIR set-aside from 3.46 percent in fiscal year (FY) 2018 to 4.5 percent in FY 2022 of any federal agency budget that provides more than $100 million for research.
AAU and the CGR today issued a statement of support for the Promoting Biomedical Research and Public Health for Patients Act (S. 2742).
Bipartisan group of 145 MCs urges increased NIH funding.
A statement by AAU on the 21ST Century Cures Act (H.R. 6) and the Brat amendment, which the House will consider.
A statement by AAU on the research and higher education provisions in the FY16 Labor, HHS, Education appropriations bills passed by the House and Senate Appropriations Committees.
Higher Education associations express concerns about Senate FY16 LHHS funding bill.
RFI: Optimizing Funding Policies and Other Strategies to Improve the Impact and Sustainability of Biomedical Research
Statement by AAU on the draft 21st Century Cures bill released on April 29, 2015, by Chairman Fred Upton (R-MI) of the House Energy and Commerce Committee and the panel’s ranking member, Rep. Frank Pallone (D-NJ).
Investments in higher education and research are proven drivers of economic growth. They are vital for the development of new technologies, processes, and a workforce that will advance our national security, our energy self-sufficiency, and our citizens’ health.